Cystic Fibrosis Therapeutics in Major Developed Markets to 2019
Reportstack has announced a new report on C ystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth. Novel treatments with disease-modifying mechanisms of action are the primary factor driving the growth of the value of the market. The positive impact of new market entrants will offset the effects of key patent losses during the forecast period. Cystic Fibrosis Transmembrane conductance Regulators (CFTR) modulators are the first type of CF...
View full press release